Regarded as one of the top honors in the field of health and medicine, election to the AAP recognizes physician-scientists exhibiting excellence in the pursuit of medical knowledge and advancing basic or translational science discoveries and their use in clinical medicine.
Mantle Cell Lymphoma Treatment Varies According to Setting
July 5, 2022
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators from Weill Cornell Medicine and other leading health institutions.
New Technology Helps Reveal Inner Workings of Human Genome
June 23, 2022
Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome, or how the genome folds. The genome is the complete set of genetic instructions, DNA or RNA, enabling an organism to function.
June 2022 EIPM Director's Memo
June 6, 2022
Dear Members of the Englander Institute,
I really enjoy talking to people about the exciting work happening at the EIPM, it can lead to all kinds of collaborations, professional opportunities, and new sources of support.
Immune Therapy Targets Cells that Cause Relapse
June 3, 2022
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical study by investigators at Weill Cornell Medicine. The new cell therapy, now being tested in phase 1 clinical trials, may ultimately help patients with AML to remain cancer-free.
New Cancer Subtype May Illuminate Treatment Strategy
May 27, 2022
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery opens the door to the development of therapies that treat this specific disease.
New video: Reinventing Medicine at the EIPM!
May 10, 2022
We hope you enjoy watching our new video and taking a tour of our facilities and laboratories and learning more about how we’re reinventing medicine, with our Director Olivier Elemento, Ph.D. Dr. Laura Martin, Hiranmayi Ravichandran, Ilkay Us, and Alexandros Sigaras, M.S.
T Cell Behavior Determines Which Tumors Respond to Treatment
May 9, 2022
Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn’t work, and new research may help explain why. When immune cells called T lymphocytes infiltrate malignant tumors, the genetic program of those T cells and the developmental path they then follow, may affect their response to immunotherapy and predict overall patient survival, according to a new study by Weill Cornell Medicine investigators. The results overturn the prevailing model of immune responses in melanoma and present different therapeutic approaches.
May 2022 EIPM Director's Memo
May 3, 2022
Dear Members of the Englander Institute,
In the past few months we have taken advantage of annual events like #DoctorsDay, #InternationalWomensDay, and #WomenInScience to celebrate and showcase our staff on social media. April brought another opportunity with #LabWeek! I hope you enjoy following our social media posts about these events as much as I do.
Celebrating DNA Day!
April 26, 2022
DNA Day is celebrated every April 25th, and as our friends at Illumina say “DNA Day isn’t just about celebrating the history of the double helix — it’s our chance to spotlight how the genome is unlocking better human health.”
EIPM Director Dr. Olivier Elemento remarked in the video below, “So sequencing is very important, it allows us to understand how different people are — and what makes every individual unique.”
EIPM Member Inducted into the Assoc. American Physicians
April 11, 2022
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the esteemed Association of American Physicians (AAP).